BTB06584
BTB06584 is a selective and IF1-dependent mitochondrial F1Fo-ATPase inhibitor without compromising ATP synthesis. BTB06584 can delays ischaemic cell death[1].
Product Specifications
CAS Number
219793-45-0
UNSPSC
12352005
Hazard Statement
H318
Target
ATP Synthase
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/BTB06584.html
Purity
99.60
Solubility
DMSO : 100 mg/mL
Smiles
ClC1=CC=C(C(OC2=C([N+]([O-])=O)C=CC(S(C3=CC=CC=C3)(=O)=O)=C2)=O)C=C1
Molecular Formula
C19H12ClNO6S
Molecular Weight
417.82
Precautions
H318
References & Citations
[1]Ivanes F, et al. The compound BTB06584 is an IF1 -dependent selective inhibitor of the mitochondrial F1 Fo-ATPase. Br J Pharmacol. 2014 Sep;171 (18) :4193-4206.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC683605-500 1x 500 µL
EGFR (Epidermal Growth Factor Receptor) (rGFR/1667), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 